Manufacturing: Page 31
-
Quotient Sciences buys UK CDMO in third acquisition of year
Not one week after unveiling a corporate rebranding, Quotient announced it would acquire the British CDMO Pharmaterials.
By Ned Pagliarulo • Nov. 16, 2017 -
Hospitals facing IV solution shortages after Hurricane Maria
The FDA has granted one of the largest manufacturers of IV solutions permission to import IV bags from its facilities in other countries.
By David Lim • Nov. 16, 2017 -
Courtesy of FujiFilm
Fujifilm boosts biopharma CDMO unit with $28M investment
The Japanese company has sped up the timeline for further expansion of its contract business, citing growing customer demand.
By Suzanne Elvidge • Nov. 9, 2017 -
'Hard' Brexit risks disrupting supply of thousands of drugs
A departure by the U.K. from the EU without a trade deal could imperil drug supply chains, a trade group of European drugmakers warned.
By Ned Pagliarulo • Nov. 8, 2017 -
Roche to shift packaging operations, trimming 235 jobs
Packaging of established, large-volume products will be relocated from the Kaiseragust site, freeing up capacity to focus on specialized medicines.
By Ned Pagliarulo • Nov. 8, 2017 -
Getty / Edited by Industry Dive
Lupin reeling after double whammy warning letter
Shares in the Indian drugmaker dropped by more than 15% on news the FDA flagged manufacturing violations at two facilities.
By Jacob Bell • Nov. 8, 2017 -
Shire moves Cinryze production in-house as manufacturing problems persist
A third-party manufacturer didn't supply enough of the hereditary angioedema drug during the third quarter, leading to slumped sales.
By Jacob Bell • Nov. 2, 2017 -
FDA to recognize GMP inspections by 8 EU drug regulators
The agreement marks a major step toward closer collaboration between the FDA and its European counterparts to regulate the production of medical products.
By Ned Pagliarulo • Nov. 2, 2017 -
Mustang Bio secures CAR-T production site
Mustang will lease a facility in the UMass Medicine Science Park as it prepares for clinical production of its CAR-T candidates next year.
By Suzanne Elvidge • Nov. 2, 2017 -
Courtesy of Sanofi
Sanofi passes on Parkinson's option, crushing Voyager's shares
While the biotech took a hit when its pharma partner exited, retaining U.S. rights for the gene therapy could be a silver lining with better economics.
By Jacob Bell • Oct. 31, 2017 -
India fights the 'lesser quality' taint in drug manufacturing
Indian drug manufacturers are looking to be bigger players in the global market, but quality control continues to be a challenge.
By Malorye Allison Branca • Oct. 30, 2017 -
Drug production in Puerto Rico still disrupted, FDA says
Despite positive updates from several large drugmakers, many facilities appear to be operating well below capacity.
By Ned Pagliarulo • Oct. 26, 2017 -
Recipharm's serialization push continues with Lisbon facility
The CDMO now has six sites with serialization capabilities, reinforcing its position as a key provider of the increasingly important regulatory service.
By Jacob Bell • Oct. 26, 2017 -
Lilly to spend $72M on upgrading insulin production
The Indianapolis pharma has earmarked $850 million for investments into its U.S. operations this year.
By Ned Pagliarulo • Oct. 26, 2017 -
Single-source contracting could speed drug development
Outsourcing to a single CMO rather than multiple for manufacturing support proved faster and less costly, a Tufts study found.
By Suzanne Elvidge • Oct. 26, 2017 -
With generics market calling, Cambrex outfits Milan facility
The API and generics manufacturer sees an opportunity for growth as certain highly potent molecules near patent expiration.
By Jacob Bell • Oct. 19, 2017 -
J&J says Puerto Rico plants returning to full operations
All of J&J's six manufacturing plants on the island are open, but the drugmaker couldn't rule out the possibility of intermittent supply shortages for certain drugs.
By Ned Pagliarulo • Oct. 19, 2017 -
Sponsored by Abbvie
CPhI Worldwide: Q&A on bilayer tablet manufacturing
Manufacturing bilayer tablets has its own unique challenges for CDMO's. Dr. Éanna Ó Maitiú, Technical Operations Manager, at AbbVie Cork, Ireland discusses the special considerations Abbvie takes into account regarding the manufacturing of these medications.
By Dr. Éanna Ó Maitiú, Technical Operations Manager at AbbVie Cork, Ireland • Oct. 19, 2017 -
Novartis shuts Colorado generics facility, cutting 450 jobs
A tightening generics market in the U.S. has prompted the Swiss pharma to consolidate production and discontinue or sell several low-growth products.
By Suzanne Elvidge • Oct. 19, 2017 -
MassBio: Massachusetts edges out California as #1 biotech hub
A recent report shows there are now more biopharma jobs in the Boston area than any other place in the U.S., while funding to the area continues to flow.
By Jacob Bell • Oct. 17, 2017 -
Pfizer sells off Colorado facility to CordenPharma
The Colorado site is one of several legacy Hospira sites that the pharma giant has sought to divest as it reshapes its manufacturing network.
By Ned Pagliarulo • Oct. 12, 2017 -
Biocon manufacturing problems stall another one of its biosimilars
The FDA rejected Biocon and Mylan's version of Neulasta as the agency awaits more chemistry, manufacturing and controls data for a recently modified facility.
By Jacob Bell • Oct. 12, 2017 -
Sanofi commits €170M to expand flu vaccines production
Vaccines are a sizable and fast-growing business for the French drugmaker, which is one of the leading players in the space.
By Ned Pagliarulo • Oct. 12, 2017 -
J&J invests $355M in Ireland, creates new jobs
Janssen Sciences Ireland is expanding its Country Cork facility, boosting manufacturing and creating new jobs.
By Suzanne Elvidge • Oct. 12, 2017 -
Sponsored by Pfizer CentreOne
Is your API ready for scale-up? What to demand from your CDMO
A CDMO that can optimize your API synthesis process early during technology transfer will reduce the risk of project delay or failure. That will also help your molecule run more efficiently in their plant. And time is money.
By Justin A. Divan, Manager, Project Management, Pfizer CentreOne • Oct. 11, 2017
Previous
